These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15811593)

  • 1. The effect of Ondansetron on memory in schizophrenic patients.
    Levkovitz Y; Arnest G; Mendlovic S; Treves I; Fennig S
    Brain Res Bull; 2005 Apr; 65(4):291-5. PubMed ID: 15811593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-tryptophan on memory in patients with schizophrenia.
    Levkovitz Y; Ophir-Shaham O; Bloch Y; Treves I; Fennig S; Grauer E
    J Nerv Ment Dis; 2003 Sep; 191(9):568-73. PubMed ID: 14504565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ondansetron in the treatment of schizophrenia.
    Bennett AC; Vila TM
    Ann Pharmacother; 2010; 44(7-8):1301-6. PubMed ID: 20516364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.
    Gallagher P; Watson S; Smith MS; Ferrier IN; Young AH
    Biol Psychiatry; 2005 Jan; 57(2):155-61. PubMed ID: 15652874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S; Pourcher E; Cohen H
    J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning related to quality of life in schizophrenia.
    Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
    Dickinson D; Ramsey ME; Gold JM
    Arch Gen Psychiatry; 2007 May; 64(5):532-42. PubMed ID: 17485605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
    Karch S; Leicht G; Giegling I; Lutz J; Kunz J; Buselmeier M; Hey P; Spörl A; Jäger L; Meindl T; Pogarell O; Möller HJ; Hegerl U; Rujescu D; Mulert C
    J Psychiatr Res; 2009 Oct; 43(15):1185-94. PubMed ID: 19426993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved p50 auditory gating with ondansetron in medicated schizophrenia patients.
    Adler LE; Cawthra EM; Donovan KA; Harris JG; Nagamoto HT; Olincy A; Waldo MC
    Am J Psychiatry; 2005 Feb; 162(2):386-8. PubMed ID: 15677607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA; Roache JD; Ait-Daoud N; Javors MA; Harrison JM; Elkashef A; Mojsiak J; Li SH; Bloch DA
    Drug Alcohol Depend; 2006 Oct; 84(3):256-63. PubMed ID: 16631323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
    Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1101-7. PubMed ID: 17475386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron alters human alcohol intoxication.
    Swift RM; Davidson D; Whelihan W; Kuznetsov O
    Biol Psychiatry; 1996 Sep; 40(6):514-21. PubMed ID: 8879472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
    Olincy A; Harris JG; Johnson LL; Pender V; Kongs S; Allensworth D; Ellis J; Zerbe GO; Leonard S; Stevens KE; Stevens JO; Martin L; Adler LE; Soti F; Kem WR; Freedman R
    Arch Gen Psychiatry; 2006 Jun; 63(6):630-8. PubMed ID: 16754836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.